Episode 34: Savolitinib in Renal Papillary Cancer – A Major Breakthrough?

Dr. Toni Choueiri discusses the results of this study, which appears to show a survival signal, but it is difficult to interpret.

Related Episodes

Episode 135: The STAR Study
Episode 122: The Uromigos Legends in GU Cancer series – Nick Vogelzang: renal cancer
Episode 117: PD1/VEGF adverse event management in renal cancer
Episode 116: Renal cancer surgery controversies at EAU
Episode 111: The randomised phase 3 CANTATA in metastatic renal cancer
Episode 109: Adjuvant pembrolizumab in renal cancer
Episode 103: Targeting the microbiome increases the activity of immune therapy in renal cancer
Episode 102: Adjuvant therapy in melanoma – how it will help inform the renal community
Episode 101: The Uromigos Paper of the Month – Belzutifan in renal cancer
Episode 99: Navigating social media from a patients’ perspective